|

Trastuzumab Injection Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • UNICANCER1
  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Breast Cancer2
  • Cancer2
  • Leptomeningeal Disease1
  • Early-stage or Locally Advanced HER2-positive Breast Cancer1
  • HER2-positive Metastatic Breast Cancer1

Other2 trials

A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
Phase 3
Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.